跳至主要内容
临床试验/NCT03656016
NCT03656016招募中不适用

Assessment of Cerebrospinal Fluid Flow Related Disorders Using a Phase-contrast Magnetic Resonance Imaging Technique.

Assiut University1 个研究点 分布在 1 个国家目标入组 87 人开始时间: 2019年3月25日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
87
试验地点
1
主要终点
To calculate different cerebrospinal fluid flow parameters at different levels of flow quantification.

研究概览

简要总结

Cerebrospinal fluid is a clear, colorless fluid that circulates in the cranial and spinal subarachnoid spaces, located between the pia and arachnoid matters. It is mainly produced by the choroid plexus, while lesser amount produced by the ependymal cells lining the ventricles. Its function includes cushioning and lubrication of the central nervous system, circulation of nutrients and waste collection providing basic mechanical and immunological protection to the brain.

详细描述

There are several disorders such as communicating and non- communicating hydrocephalus, normal pressure hydrocephalus, cystic cerebrospinal fluid collections, Chiari malformation, syringomyelic cyst and arachnoid cyst that can change the cerebrospinal fluid dynamics.

Rapid advances in imaging techniques have remarkably improved the diagnosis and treatment of these disorders.

Phase contrast magnetic resonance imaging is a rapid, simple and non-invasive technique which is sensitive to even small cerebrospinal fluid flows, and can be used to evaluate cerebrospinal fluid flow both qualitatively and quantitatively. Cine phase contrast magnetic resonance images show cerebrospinal fluid flow in a dynamic, more easily appreciable, and in a more pleasing manner, allowing the delineation of obstruction, if present, along the portions of cerebrospinal fluid pathway where obstruction is common.

Phase contrast magnetic resonance imaging can be used to discriminate between communicating hydrocephalus and non-communicating hydrocephalus, to localize the level of obstruction in obstructive hydrocephalus, to determine whether arachnoid cysts communicate with the subarachnoid space, to differentiate between arachnoid cysts and subarachnoid space, to discriminate between syringomyelia and cystic myelomalacia, and to evaluate flow patterns of posterior fossa cystic malformations.

This imaging method can also provide significant information in pre-operative evaluation of Chiari 1 malformation and post-operative follow-up of patients with neuroendoscopic third ventriculostomy and ventriculoperitoneal shunt.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients with different age groups and both sex with clinical and routine conventional magnetic resonance imaging findings suggestive of cerebrospinal fluid flow disorders.

排除标准

  • Patients with contraindications for MRI, e.g. an implanted magnetic device, pacemakers or claustrophobia.
  • Patients with VP shunts
  • Patients with ventriculomegally due to brain SOLs.

结局指标

主要结局

To calculate different cerebrospinal fluid flow parameters at different levels of flow quantification.

时间窗: base line

measure Systolic stroke volume and Peak systolic velocity at different levels of flow quantification

次要结局

  • To correlate these parameters to the normal values of age matched control group(baseline)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Shimaa Hassanien Hassanien Bakr

principal Investigator

Assiut University

研究点 (1)

Loading locations...

相似试验

已完成
不适用
An investigation on spinal fluid in patients with sciatica-type or nerve-type pain of the lower limbeuropathic lower limb painNervous System Diseases
ISRCTN34007592Trinity Translational Medicine Institute12
尚未招募
不适用
Cerebrospinal Fluid and Psychiatric Disorders (CSFPsych)
NL-OMON47432niversitair Medisch Centrum Utrecht500
进行中(未招募)
1 期
An open-labelled study of the cerebrospinal fluid pharmacokinetics of intravenous Kineret® in patients with subarachnoid haemorrhage - IL-1RA in SAH PK STUDY 2This is a pharmacokinetic study in patients who have had a Subarachnoid Haemorrhage and who have had an external ventricular drain inserted for clinical management reasons, must usually for the treatment of hydrocephalus.MedDRA version: 9.1 Level: LLT Classification code 10042316 Term: Subarachnoid haemorrhageMedDRA version: 9.1 Level: LLT Classification code 10052947 Term: Ventricular drainageMedDRA version: 9.1 Level: LLT Classification code 10020508 Term: Hydrocephalus
EUCTR2007-002337-36-GBSalford Royal NHS Foundation Trust100
终止
不适用
Cerebrospinal Fluid Collection and Repository StorageNervous System Diseases
NCT01862107National Institute of Neurological Disorders and Stroke (NINDS)51
已完成
不适用
A study to examine cerebrospinal fluid transitivity and efficacy of afatinib in carcinomatous meningitis patients with non-small cell lung cancer patients harboring EGFR mutation.carcinomatous meningitis patients with NSCLC harboring EGFR mutation
JPRN-UMIN000014065Kinki-Chuo Chest Medical Center10